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The aim of this special issue is to provide the scientiﬁc audi-
ence with an up-to-date review of pluripotent and tissue-
speciﬁc stem cells and their diﬀerentiation in combination
with cellular engineering in the quest to develop novel
regenerative therapies.
The ﬁeld of regenerative medicine is focused on the
creation of functional tissue units to either repair or replace
compromised tissue or organs in vivo. The ﬁeld therefore
oﬀers the promise that, in the future, scientists will be able
to grow tissues in the laboratory and use them safely as
extracorporeal devices to stimulate endogenous repair [1]
or implant them when the body cannot heal itself, but only
when cell-based therapies are deemed safe and eﬀective [2,
3]. If successful, such an approach would have a signiﬁcant
impact on the problem of the shortage of donor organs
available for transplantation.
The collections of papers that make up this special issue
provide broad-ranging coverage of the ﬁeld and provide
comprehensive and up-to-date reviews of human develop-
ment and the relationships that exist between development,
regeneration, carcinogenesis, and the role of stem cells in
these processes (Kung et al., 2010). There is a focus on appli-
cation of this knowledge using human embryonic stem cells
which have the potential to provide novel biological models
and medical devices (Sharma et al., 2010). Additionally, we
discuss adult stem cell populations exploring their in vitro
expansion (Wells, 2010) and plasticity (Lui et al., 2010),
essential to regenerative medicine and tissue engineering.
This is supported by the review article on generating the
correct cell-cell and cell-environment interactions in these
processes (Titushkin et al., 2010).
The ability to prepare homogeneous preparations of
somatic cells for regenerative medicine will necessitate the
development of methods which are simple and do not
expose derivative cell populations to greater stress. A highly
attractive procedure,dielectrophoresis, shows great potential
in population enrichment and in stem cell sorting and is
discussed in this special issue (Pethig et al., 2010). It is likely
that technologies which do not require cell surface labels will
play an increasing role in regenerative medicine.
Stem cell-based therapies have been used successfully
in the past, and many more are predicted for the future,
therefore, it is critical that we produce cell types which are
stable and contribute to tissue homeostasis in vivo. A crucial
element of tissue homeostasis and organ stability is DNA
repair. This process protects stem cells in both embryonic
and adult tissues from genetic damage thereby maintaining a
stable genome. DNA repair is a fast and eﬃcient process, but
it can prove problematic when stem cells undergo malignant
transformation (Frosinaetal.,2010).Inordertogainabetter
understandingofthisprocessnoninvasivecellulartechniques
have been developed to accurately determine diﬀerences in
normal and transformed cell lines. Raman spectroscopy is
one such example and has provided insight into changes
in DNA and RNA concentrations during the lifecycle of a
cell, and, as such, we have highlighted this technique as a
promising approach in this issue (Downes et al., 2010).
We hope that this collection of papers stimulates interest
within the academic community and provides a basic and
up-to-date overview of key areas in regenerative medicine,
cell biology, and tissue engineering.
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